| 2019 | Press Release |
|---|---|
| 8/08/2019 | Biological Industries USA Adds Strategic Offering of Small Molecules to its Stem Cell PortfolioStrategic portfolio of small molecules designed to streamline workflows for research in diabetes, neural disorders, and cardiovascular disease. |
| 2018 | Press Release |
|---|---|
| 12/13/2018 | Biological Industries USA Announces Call for Applications for 2019 Stem Cell Research AwardsThe 2019 BI-USA Stem Cell Research Awards are designed to encourage cutting-edge scientific research using a variety of cell types that are critical for regenerative medicine applications, including human stem cells (hPSCs and hMSCs), T cells, and endothelial cells. |
| 10/30/2018 | Biological Industries USA Adds Human Mesenchymal Cells to its Stem Cell Portfolio in Partnership with StemExpress®Strategic partnership for the non-exclusive worldwide distribution of StemExpress’ human bone marrow-derived mesenchymal stem cells (BM-MSCs). |
| 06/06/2018 | Biological Industries USA Adds Vitronectin XF™ to its Stem Cell Portfolio Through Agreement with Primorigen Biosciences, Inc.BI-USA has performed extensive evaluation of Vitronectin XF™ in combination with BI’s NutriStem® hPSC Medium, resulting in consistent long-term culture of pluripotent cells in a chemically defined, xeno-free environment. |
| 01/23/2018 | Biological Industries USA Announces MSC and Stem Cell Research Award, Including Conference Travel, Laboratory Reagents, and Potential Publicity for Researchers |
| 2017 | Press Release |
|---|---|
| 12/15/2017 | Biological Industries USA announces Growth and Recruitment of New HiresConnecticut-based cell culture products provider announces new positions as it looks to expand in response of the success of its stem cell reagents and custom media manufacturing business. |
| 05/12/2017 | Biological Industries USA To Support Training Programs For Young Scientists Through Partnership With Non-Profit Institute Pathways To Stem Cell ScienceExciting partnership designed to support real-world laboratory skills training in regenerative medicine for early career scientists (high school to college level and beyond). |
| 03/17/2017 | Biological Industries USA Signs Agreement with Mill Creek Life Sciences to add PLTMax® Human Platelet Lysate to its Growing Stem Cell PortfolioPartnership announced for distribution of Human Platelet Lysate, a product derived from human platelets and offers unparalleled cell growth and cytogenetic stability of adult stem cells over fetal bovine serum (FBS). HPL is available in research and clinical grades and has been used in more than 30 clinical trials worldwide, including several Phase III trials. |
| 2016 | Press Release |
|---|---|
| 11/30/2016 | Biological Industries Announces FDA Drug Master File Acceptance For NutriStem hPSC XF MediumThis Drug Master File will enable BI cell therapy customers to integrate NutriStem® hPSC XF Medium into their clinical trial protocols more easily. |
| 06/21/2016 | Biological Industries USA to Participate at the International Society for Stem Cell Research Annual Meeting 2016Announces the launch of new xeno-free endothelial cell culture system suitable for clinical applications. |
| 2015 | Press Release |
|---|---|
| 10/27/2015 | Biological Industries Expands to the United States, Providing Innovative Research Technology to the U.S. Life Sciences MarketBI-USA will focus on high-growth, establishing cell culture training programs, and expanding collaborations within the stem cell and conventional cell culture fields. |
